HCA Healthcare Inc
SWB:2BH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (13.7), the stock would be worth €480.83 (31% upside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 10.5 | €367.2 |
0%
|
| 3-Year Average | 13.7 | €480.83 |
+31%
|
| 5-Year Average | 11.7 | €410.64 |
+12%
|
| Industry Average | 21.8 | €764.95 |
+108%
|
| Country Average | 21.9 | €766.71 |
+109%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
HCA Healthcare Inc
SWB:2BH
|
96.8B EUR | 10.5 | 14.3 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 93.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.7B ZAR | 14.5 | 14.1 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.9B MYR | 34.4 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.7B ZAR | 9.5 | 4.6 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.7B BRL | 107.3 | 18.1 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.9B USD | 6.1 | 9.4 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
100.5B CNY | 24.1 | 29.8 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 43.2 | 60.8 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.7B USD | 29.2 | 30.7 | |
| ID |
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
184.2T IDR | -290.3 | -705.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.1 |
| Median | 21.9 |
| 70th Percentile | 36.5 |
| Max | 3 188 432.5 |
Other Multiples
HCA Healthcare Inc
Glance View
HCA Healthcare Inc., a titan in the American healthcare landscape, traces its origins back to 1968 when Dr. Thomas F. Frist Sr., his son Dr. Thomas F. Frist Jr., and businessman Jack C. Massey founded the company with a vision to provide quality care in hospital settings. Fast forward to today, HCA operates an extensive network of 182 hospitals and over 2,300 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers, and physician clinics, spreading its healthcare prowess across 20 U.S. states and the United Kingdom. At the core of its operations is a robust infrastructure dedicated to delivering comprehensive medical services ranging from basic emergency care to intricate surgical procedures and specialized treatments. This strategic breadth allows HCA to harness economies of scale, enhancing operational efficiency and improving patient outcomes. The financial engine fueling HCA Healthcare is multifaceted, driven primarily by patient services revenues. This encompasses everything from inpatient care, outpatient services, and ancillary services like laboratories and imaging. Such diverse offerings not only boost the company's revenue streams but also position it to adapt to evolving healthcare needs and regulatory changes. By continuously investing in state-of-the-art medical technology and adopting innovative care models, HCA enhances its service quality and patient retention, which results in stabilized financial performance. With a focus on both urban and suburban communities, HCA leverages its clinical expertise and geographic reach to capture significant market share, fostering a sustainable and profitable business model that underscores its stature as a leader in the healthcare sector.